参考文献/References:
[1].Fülster S,Tacke M,Sandek A,et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)[J]. Eur Heart J2013,34(7):512-519.
[2].Cruz-Jentoft AJ,Baeyens JP,Bauer JM,et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People[J]. Age Aging, 2010,39(4):412-423.
[3].Chen LK,Liu LK,Woo J,et al. Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia[J].?J Am Med Dir Assoc,2014,15(2):95-101.
[4].Chen LK,Woo J,Assantachai P,et al. Asian Working Group for Sarcopenia:2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J]. J Am Med Dir Assoc,2020,21(3):300-307.
[5].Malmstrom TK,Morley JE. SARC-F:a simple questionnaire to rapidly diagnose sarcopenia[J]. J Am Med Dir Assoc,2013,14(8):531-532.
[6].王晓英. 老年肌少症问卷的汉化及运动疗法对肌少症治疗效果的meta分析[D]. 河北医科大学,2018.
[7].Cao L,Chen S,Zou C,et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people[J]. J Nutr Health Aging,2014,18(3):277-283.
[8].Malmstrom TK,Miller DK, Simonsick EM,et al. SARC-F:a symptom score to predict persons with sarcopenia at risk for poor functional outcomes[J]. J Cachexia Sarcopenia Muscle,2016,7(1):28-36.
[9].Kotlarczyk MP,Perera S,Nace DA,et al. Identifying sarcopenia in female long-term care residents: a comparison of current guidelines[J].?J Am Geriatr Soc,2018,66(2):316-320.
[10].Rolland Y,Dupuy C,Abellan Van Kan G,et al. Sarcopenia screened by the SARC-F questionnaire and physical performances of elderly women:a cross-sectional study[J].?J Am Med Dir Assoc,2017,18(10):848-852.
[11].Urzi F,?imuni? B,Buzan E. Basis for sarcopenia screening with the SARC-CalF in nursing homes[J]. J Am Med Dir Assoc,2017,18(11):991.e5-991.e10.
[12].Barbosa-Silva TG,Menezes AM,Bielemann RM,et al. Enhancing SARC-F:improving sarcopenia screening in the clinical practice[J]. J Am Med Dir Assoc,2016,17(12):1136-1141.
[13].Morley JE,Anker SD,von Haehling S. Prevalence,incidence,and clinical impact of sarcopenia:facts,numbers,and epidemiology—update 2014[J]. J Cachexia Sarcopenia Muscle,2014,5(4):253-259.
[14].Chen LK,Lee WJ,Peng LN,et al. Recent Advances in Sarcopenia Research in Asia:2016 Update From the Asian Working Group for Sarcopenia[J]. J Am Med Dir Assoc,2016:17(8):767.e1-e7.?
[15].Bekfani T,Pellicori P,Morris DA,et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life[J]. Int J Cardiol,2016,222:41-46.
[16].[16]Valentova M,Anker SD,von Haehling S. Cardiac cachexia revisited:the role of wasting in heart failure[J]. Heart Fail Clin,2020,16(1):61-69.
[17].[17]Azhar G,Wei JY. New approaches to treating cardiac cachexia in the older patient[J]. Curr Cardiovasc Risk Rep,2013,7(6):480-484.
[18].[18]Haykowsky MJ,Brubaker PH,Morgan TM,et al. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass[J]. J Gerontol A Biol Sci Med Sci,2013,68(8):968-975.
[19].[19]von Haehling S,Garfias Macedo T,Valentova M,et al. Muscle wasting as an independent predictor of survival in patients with chronic heart failure[J]. J Cachexia Sarcopenia Muscle,2020,11(5):1242-1249.?
[20].[20]Saitoh M,Ishida J,Doehner W,et al. Sarcopenia,cachexia,and muscle performance in heart failure:review update 2016[J]. Int J Cardiol,2017,238:5-11.
[21].[21]Dos Santos MR,Sayegh AL,Bacurau AV,et al. Effect of exercise training and testosterone replacement on skeletal muscle wasting in patients with heart failure with testosterone deficiency[J]. Mayo Clin Proc,2016,91(5):575-586.
[22].[22]von Haehling S,Ebner N,Dos Santos MR,et al. Muscle wasting and cachexia in heart failure:mechanisms and therapies[J]. Nat Rev Cardiol,2017,14(6):323-341.
[23].[23]王永春,蒲荣喜,杨忠.增龄性骨骼肌减少症的细胞及分子机制研究[J].中国老年学杂志,2016,36(11):2799-2802.
[24].[24]Mankhong S,Kim S,Moon S,et al. Experimental models of sarcopenia: bridging molecular mechanism and therapeutic strategy[J]. Cells,2020,9(6):1385.
[25].[25]Adams V,Linke A. Impact of exercise training on cardiovascular disease and risk[J].?Biochim Biophys Acta Mol Basis Dis,2019,1865(4):728-734.
[26].[26]Liguori I,Russo G,Aran L,et al. Sarcopenia:assessment of disease burden and strategies to improve outcomes[J]. Clin Interv Aging,2018,13:913-927.
[27].[27]Suzuki T,Palus S,Springer J,et al. Skeletal muscle wasting in chronic heart failure[J]. ESC Heart Fail,2018,5(6):1099-1107.
[28].[28] Naseeb MA,Volpe SL. Protein and exercise in the prevention of sarcopenia and aging[J]. Nutr Res,2017,40:1-20.
[29].[29]Pasiakos SM,McClung HL,McClung JP,et al. Leucine-enriched essential amino acid supplementation during moderate steady state exercise enhances postexercise muscle protein synthesis[J]. Am J Clin Nutr,2011,94(3):809-818.
[30].[30]Dupont J,Dedeyne L,Dalle S,et al. The role of omega-3 in the prevention and treatment of sarcopenia[J].?Aging Clin Exp Res,2019,31(6):825-836.
[31].[31]Sumukadas D,Witham MD,Struthers AD,et al. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial[J]. CMAJ,2007,177(8):867-874.
[32].[32]Zhou LS,Xu LJ,Wang XQ,et al. Effect of angiotensin-converting enzyme inhibitors on physical function in elderly subjects:a systematic review and meta-analysis [J].?Drugs Aging,2015,32(9):727-735.
[33].[33]Brioche T,Kireev RA,Cuesta S,et al. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism:improvement of protein balance and of antioxidant defenses[J]. J Gerontol A Biol Sci Med Sci,2014,69(10):1186-1198.
[34].[34]Temel JS,Abernethy AP,Currow DC,et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2):results from two randomised,double-blind,phase 3 trials[J]. Lancet Oncol,2016,17(4):519-531.
[35].[35]Rooks D,Praestgaard J,Hariry S,et al. Treatment of sarcopenia with bimagrumab:results from a phase II,randomized,controlled,proof‐of‐concept study[J]. J Am Geriatr Soc,2017,65(9):1988-1995.